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INTRODUCTION

The existance of the disease process termed
amyloidosis hc;s b6en recognized since the middle of
the nineteenth century.

B,,t even after a span of

nei::u' ~-Y one hundred years, our knowledge of this subject h&s taken only a V5ry short step forward.

Text-

books of th& present time are content to treat this
subject as one of the lesser pathological degenerative processes end rnerely state trrnt it is a condition of doubtful origin and unknmvn nature associated in the ma:in with ct.;ronic suppure_tive diseases.
My curiosity in this vroces~ was &roused when
I observed a case of tuberculosis of the hip a.nu
was asked of the potentialities of amyloidosis in
such a condition.

The li tersture was of 11 i:.tle value

in summarizing this complex situation.

The mechanism

of &"'Tlyloid formation 2nd its miture are almost a
mystery.

Experimental inVEostigetors ar-e groping in

a stete of chaos.

Unfortun~,tely for tl,em the various

amino-acids do not weer identifying labels nor do
they stain characteristically.
It is in an ettempt to tie together some of tbe
known features, questioneble aspects, and numerous
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hypo theses tbn t tbi s paper is being written.

Wo

plRce in the .i.i ter,,"ture could I find a complete and
comprebensi ve r·eview of this sub_iect with all its
varioc: s phases.

For tbf:; t reason I will include

nearly every manner in which this disease may maniftst itself, from the mere mentioning of Audison's
disease to a fairly complete presentation of renal
amyloiuosis, as well as the general naGure ana pathology of the disease.

P:be1•efore, it is in an attempt

1

to bring some order out of a confused state that I
present this review of the literature on tbe subject
of amyloidosis.

C • .::;. R.

2.

EAhLY HIST0RY

Of the meny retrograde processes that may take
place in the human body, 0ne of the most interesting
is that of the formation of arnyloid, interesting oecause of its elusiveness so far as experimental
methods are concerned in respect to its origin, its
distribution, the mechanism of its formation, and
even its ex2ct chemical composition.

The mechanism

of amyloid production is still replete with fascinating hypotheses, although it does seem as if some
order were being brought out of the ctaos that has
existed for years.
The formations conceived by Virchow (1) in 1851
as "a.myloid bodies 11 a.nd formerly described as
"concentric, sphE.ric1::l clotsu, included not only the
so-called amyleceous bodies (Purkinje), Kohlrauch's
colloid bodies of the kidney and prostate concretions,
but 21s0 venous .stones, brain sand, and semisolid
concretions of the pancreas.
the name

11

Virchow has pr·oposed

amyloidn, used in botony for the genera.l

conception of concentric laminetion, because of the
concentric lamination which was so common to all
those bodies and which related them with starch
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granules.

With the discovery of the color reactions

now associated with a.myloid end which ere similsr
to those for cellulose, the ctemical notion took the
place of the morphological; brain sand and venous
stones, which do not have these rc:::actions, were
eliminated from the category of amylaceous bodies.
The conclusion that vegetable cellulose is present
in human beings was the most importBnt notion to
Virchow.

This conclusion he still maintained even

after his discovery of the protein nature of amyloid.
Owing to its color reactions it was later possible
to recognize th8t Christensen's Sago spleen was an
orge.n conta~cning amyloid deposits despite the absence
of concentric lamination.

Thi. 1\JA'I'UhE Al~D SOURCE OF AMYLOID

Amyloid is generally believed to be a mixture
of complex protein substances.

'The "Lime honored

formula of Kra.vkoff (2) in lbG'I, making amyloid a
combination of protein end chondroitin-sulfuric acid
has been repeatedly 'iuestioned, though emphasized
as fact in many of the older texts.

Mayeda (3), in

1909, and Lucke (4), in 1921, found no evidence of
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sulfuric acid in amyloid, and Eppinger (5), also in 1921,
isolated a tumor mass of amyloid and found it contained no
sulfur Pt all.

More recent studies suggest

t any such combined relationship is only incidental,
and dependent 1�on certain physico-chemical properties of
the amyloid after its initial formation in the tissues.
Dresel (ti) reports such properties by finding
chondroitin-sulfuric acid in the blood of patients
suffering from amyloidosis and lipoid nephrosis.

He

believes its prEcsence is due to the retention of the
substance by tr.Le me.lfunctioning kidneys.

In addition,

Scbmiedeberg' s 1nvestige.t1ons render it highly probsble
thut the substance wr�ich is responsible for the iodinesulfuric acid reactions, beretofore

believed dependent

on the presence of chondroit1n-sulfuric acid, is a member
of the carbohydrates, and that this substance is only e
product of metabolism of hyaloidin 'hhich is in stable
combination with the protein substance.
Thus for years the question as to the nature of the
amyloid substance has risrnained unsolved--and has not been
sa'tisfactorily answered to date.

Even at this present time

workers in this field are content to agree with Eppinger
(5) in his belief that amyloid is a com�lex protein
substance, varied in its
5.

composition and consists of
amino-acids.

0

number of different

The originally conflicting views a.s

to the nature of amyloid are now explainable by the
differences in methods used; the elementary analyses
of' variO-.;_S investigators now fund.amentally agree.
Since 1004, when Neuberg .:·elated amyloid to the
histones it has been regarded as a substance foreign
to the natural protein supply of man.

The theory

of the formation of amyloid concluded from this is
that the substance evolves from the toxic decomposition of protein.
A :eevolutionary influence upon the chemical
conception of amyloid. came from Scbrriedeberg's {7)
report to the effect that the elementary formula
obtained with amyloid mechanically isolated from the
spl8en, ga.ve evidence of a highly molecular substance
which is identical with or closely related to serumglobcJlin.

This is the opinion still held to be the

actual status by many of todays investigators including Letterer ( 6), w.bo is of the opinion that the
increased loss of cellular globulin is the first
condition of amyloidosis.

This shows that amyloid

is formed not from the splitting off of a protein
molecule but by a change within the molecule.

6.

Hence,

in diseases 1 ading to amyloid digeneration, both
the formation of the protoplasmic protein and
de str·uction of the excess serum-albumin and serumglobulin are stopped, and the excess accumulated
thereby is treated, as it were, as a foreign body,
that is--deposited in the transformed condition as
amyloid.

This, however, offers no ex_plai'lation for

production of the so-callea primary amyloid, which
will be discussed later.
The recent chei,;ical st·i1dies by Hass and Schultz
{\:I)

again emphasizes that arnylold varies considerably

in its composition, but that it q,Jite regularly
contains two protein fractions which they term "A"
and

11

B 11

•

Bo th of trH' se resist extra.ction from the

tissues by buffered phosphate soluti8ns until a pH
of eleven is reached.

The "A" fraction makes up

about 90% of the total protein.

This fraction may

be obtainea by precipitation from neutralized buffer
solution with half satur2ted ammonium sulfate in
the presence of acetic acid.

The smaller fraction

"B" is likewise precipitated from neutralized buffer
solution by half saturation with ammonium sulfate
but can be redissolved by dilute acetic acid and
di stilled water.

'I1he se authors report in addition
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to these features which were common to all amyloid
material tbey o-btained, that ::n the liver and in the
liver only as studied in thin histologic preparations,
the amyloid had the property of non-homogeneous birefringence.

This property disappeared during the

usual ext1°action procedure and did not reappear on
subsequent acidification.

They noted further in

those cases which had received Congo re~ that solution
of the combirn,tion was much more difficult, and that
the Congo red could only be separated from the
a.~yloid protein matrix in the alkaline hydrogen
range of eleven or more required for the solution of
the amyloid itself.

TLey e11-;phasize that tLis Congo

red-amyloid union is m~:rely foI•tui tous but of importance in recognizing the fact that other circulating substances with similar general properties
might just as easily combine with the amyloid matrix.
It is interesting to speculate whether tnis may not
e&sily account for the many earlisr contradictory
reports regarding the composition of &lllyloid.
It is unfortunate thet even today we ere unable
to state an exact, thou_gh variable, nature of amyloid.
The findings of Hass and Schultz are too recent and
not yet complf::,te enough to give an acc11ra.te and
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complete answer to the question.

Even yet we must

content ourselves by saying this substance is a
highly resistant compound protein, being unaffected
by pe~tic digestion, insoluble in water, very
slightly soluble in strong acids, but readily soluble
in strong alka.iis, and that the chemical composition
varies, depending upon the source of amyloid.
The \...luestion naturally arises:
source of the amyloid substance?

%'hat ls the

Koletsky and

Stecher (10) have dividtd a.myloidosis into fo.ir
groups; (a)

second&cry, (b) primary, (c) e.myloidosls

associated with multiple myeloma and (d) tumor
formj_ng amyloidosis.

They state that the latter

three all resemble the primary form in distribution
and character, that is, the mesodermal structures.
Though this classification is satisfactory, overlapping
may occur.

For example, amyloid disease of unknown

causation (i.e. primary) may involve chisfly the
parenchymatous organs, such as 1.i v,;:;r, spleen, kidneys,
and adrenals, and seco·dsry amyloidosis may involve
mesodermal tissues (10).
The so-called secondary amyluidosis is the form
to which most attention has been directed in the literature.

The clinice.l pict,re which has come to be
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known as amyloidosis has long been associated with
various chronic westing diseases, most frey_uently
complicating tuberculosis and other diseases in
which chronic suppuration occurs, such as osteomyelitis, pulmonary abscess, pyelonephritis, and
less often, syphiiis and cancer.

Certain cbror.cic

diseases which lack obvious suppuretive processes

have occasionally shown amyloid deposits are Hodgkin's
disease (11), cirrhosis of the liver, leukemia, and
chronic atrophic arthritis (12).

Higuchi (13), in

asse:::nDl.ing the autopsy findings of his own and other
European hosi:,i t: al s, found in a total of 72,050
autopsies llb9 cases of a.myloid degenerati0n, of
which 75.E% were tuberculosis patients.

In contrast

to these are the figures published by Cummins (14)
from a smeller se.cies in which he found 123 cases
of amyloid degenera,ion in a total of 236 autopsies
on tuberculosis patients.

It may be noted that

Cummins stated in his publication thst he used a
specific stain (methyl violet), vvhereas Higuchi ma.de
no note of his staining prc,cedures.

In a total of

1727 necropsies reported by Rosenblatt (lb) there
were 1276 non-tuberculosis cases and 451 tubt;rculous
patients.

There was an incidence of amyloidosis in
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the non-tuberc~losis group of l.G%, and in the
tuberculosis cases the a.myloiaosis was present in
24.4% of the cases.

The importance of tuberculosis

in amyloid disease was stressed by Saleeby

(16), who

reported it to be the etiologic agent in 41 out of
50 cases of 1->enal amyloidosis.

Other a.utbors,

including Thomas (1'7), Feters (18), Grayzel (l\:;),
and Dixon ( 20) 4uote s·..:.ch percentage fig·,re s ranging
from 38;~ to 7V/o of all tuberculosis autopsy cases
sLowing evidc,mce of amyloidosi s.
Of interest is the very recent work done by
Doctor J.B. Arey (~l) on the nature of the hyaline
changes in the islands of Langerhans in diabetes
mel1itus.

He reports that such hyaline is actually

amyloid end. "that it occurs perica.pillary in distribution in the islands of Langerhans in 16.6% of nondiabetic patients end in 71.1% of all Qiabetic
patients over fifty years of ege.

He reports that

there is no ½.ualitative difference between the amyloid
deposits in persons with and persons without diabetes.
These figur·es are significant of amyloidosis occ•.c.rring
commor.J.y, though usually unrecognized, in a chronic,
though nonsuppuretive disease.

tG

is also interesting

to speculate as to the cause and effect relationship
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in such findings in diabetes mellitus.
A great change took place in the investigations
of emyloldosls when Kuczynski (;c2) from the Institute
of Berlin in 19~;;;: experimentally produced s,,ch
changes in mice.

Tbe question of whether the

administration of protein in the form of casein or
nutrose resulted in its deposition as amyloid or
whether it stimulated the formati•:n of amyloid in
the organism was answered in the latter alternative
by the work of Letterer (8) in 1925, who was able
to enlarge the sphere of substances producing amyloid

to embr>ace such materials as colloidal sulfur end
colloidal selenium.

Butt (23) has produced amyloid

nephrosis in rabbits by injections of manganese.
Since all these subst&nces produce hyperglobulinemia,
while the increase of globulin fails in the animals
which contr,_in amyloid deposits, it is probable that,
in thes~ animals the globulin formed by the cells
is not transferred by the lymphatics to the blood,
but is consumed in the for•mation of amyloid.

'1he problem of' whetLer amyloid is

e

degenerative

profu!ct or an infiltrative materiel is still a som~v.hst open '1uestion.

Chief proponents of the

degeneretive school are Ferraro and Damon (~4).

12.

These workers have made beautif1,,l microphotographs
of m1croglia and oligodendroglia of the central
nervous system undergoing primHry nuclear degeneration,
swelling of the cell cytoplasm and followed by
amyloid degenerrtion of the de&d msterial.

'l'he

cells then fragmented, loosing the filamentous
processes--leev1ng a final stBte of rounded corpora
amylec1a.

Accordir..g to del Rio HortE g1;. ( 25), the

amylcid is due to penetration of the cell from wiLhout due to a stesis in cire11l8tion wi tb collection
of Bmyloia outside the cell with lowering of cel1.ular
tension, th1 •s favoring the penetration of ·the emyloid
into the cell, ttere to bec0me crystalized.
Of great interest in t~is line is t~e work done
by Peters (18) as he reports on ten cases in whict
epicellular and pericellDlar deposition of amyloid
predominated.--as compared to only two cases in
wLich t:be cel.1.uler deposits were noticed.

Complete

rings e.nd shells of emyloid ar01. '.nd cells could be
observed and the,se cells underwent atrophy leaving,
empty arnyloid shells.

Tbe atrophy may have been due

to pressure or to la.ck of nourisbmt:nt--or both.
these changes were noted in t:he adrena.l cortex in
amyloidosis secondary to pulmonary tuberculosis.

16.

In other tis:mes also amyloid was found deposited
on the cells.

this makes it difficult to understand

why the so-called old doctrine of the deposition of
amyloid in the interstices of the mesenchyrnal tissues
was not long ago abandoned.

In the literature

references are made to the deposition of e_myloid on
cells but without any indication as to doubt of the
ve.lidity of Ue old doctrine.

'l'hus Benecke and

Bonning (26) wrote of amylcid deposits in the heart
muscles as a

0

walling in of the muscle cells".

Hueti=:r (27) said that in cartilage the amyloid is
deposit<';d first ilon the walls of tbc: caI'tilage cells".
Arnyloict deposits on epithelial eel.ls, or more
exactly, between epithelial cells and the tunica
propria of the renal tubules have been described
by Dixon (GO).

In the intima of small veins small

aeposits of pmyloid may occur on the epithelial
cells, sometimes causing these cells to protrude
into the lumen, as expressed by Schmidt (28).
Susman (G~) upholds the infiltration theory from
his experiments with the ap~lication of barium
hydroxide to the amyloid substance, dissolving it
and leaving behind atrophic pa1·enchymal cells.
Thus by gathering all the known data, one can
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construct a plausible theory which to dete offers a
satisfectory explanation of the mecbanism in the
production of amyloid.

The injected material of

experimental studies can be dismissed as the possible
source of tbe amyloid, or even as one of the contributors (Grayzel, et al. 19).

In the first piece,

the emount introduced does not influence the re_te
of production of amyloid.

It is whoLLJ dependent

on 1,he number of innoculetions and the period of
time during which the irri temt is administered.

In

tht. second place, the composition of amyloid is
ind.e:i;.,t,ndent of tbe chemical nature of tbe substance
given pa.renterslly.

Different protein compounds

and inorganic subst~nces will produce amyloidosis
and the deposition of practically identical
lardeceous material.
The introduction of a foreign toxic substance
results in the destruction of body protein.

It

wes shown by Mbnaie end Rockwood (~uoted in Greyzel,
19) thPt the intrBvenous administr&tion of edestin
or c~sein to a dog caused the metabolism of protein
whicll was far in excess of L,hat ordin&rily occurring
in the dog plus tbat of the introduced protein.

Per-

haps the injected substance produces a disturbance
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of protein metabolism.

It has been definitely proved

by chemical analysis that amyloid 1s a complex

protein substance, es stated previously.
st,bstance must be of protein composition.

Its mother
This

might be supplied from ingested protein, from deposited protein, or from tiss'J.e protein.

That an

excessive and almost exclusive intake of protein
might cause amyloidosis must also be kept in mind
because amyloidosis hes been produced in albino mice
by feeding of a rich protein diet of cheese, bread,
the protein of chicken eggs, and milk (Dixon, 20).
It has ·been demonstrated by Voit s.nci Lanuois ( ~.uoted
by Lusk, 30) that ingested protein end deposit
procein are readily metabolized, but that living
tissue protein is y_.:ite resistant.

This indicates

thf:t the organism is far better able to metabolize
and dispose of the products of exogenous than that
of endogenous protein metabolism.

Conse(ruently,

excessive destruction of tissue protein with
liberation of such protein would pla.ce a severe
metabolic bur•den on the animal.

That protein can

circulate in the blood and be transported from one
tissue to another• is proved by tbe work of lvliescher
(Q,,10ted by Lusk--page eO, 30).

16.

HE- showed that the

marked development of the genital organs of starving
salmon occurred as a result of the transportetion
in the blood of proteins from the muscles.

However,

the infiltration of amyloid in certain tissues is
more than

F;

simple precipi ta.tion or separs_tion of

circulating protein.

The absence of universal

deposition of emyloid in the organism, particularly
at the beginning of the disease, and the constancy
with which certain sites are elected suggest that
some oth~r factor or factors enter into this process.
The early localization of amyloid m&terial in the
wandering and fixed cells of the reticulo-endothelial
system in the spleen and liver shows an interaction
-which calls for an explanation.

Susman (29) reports

thet the spleen holds some special importance in
amyloidosis because the injection experiments are
invariably negative in animals from which the spleen
has been removed.

I could find no other reference

to such a finding in the literature.

The intra-

cellular incl,- sion of arnyloid by the wandering macrophages and in the phagocytic fixed tissue cells of
the circulating toxic protein.

The intimste

association of the liver and kidney with the detoxific&tion and excretion of bacterial products and
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toxins from other sources, the mPrked response
always associated with the splEcen under such circumstances indicate that these organs a.re the ones
most liable to alteration through the invasion of
orgenisms or toxins.

Moreover, this is emphasized

by the fact thet the situation of splenic lesions
in cases of acute infection and in amyloictosis are
strikingly similar.
For a time only intracellular amyloid is evident
objectively (Grayzel, 19).

This may denote absence

or such insignificant amounts of extrHcellular
material that they cannot be demonstrated histochemically.

With the continued progression of the

process, extracellular amyloid becomes apparent and
soon fuses with the amyloid from the cells, which
about this time, undergo disintegration (Peters, 18).
The extracellula_r• deposition of amyloid may be due
to the exhaustion and inability of the fixed and
wandering cells of the reticulo-endottelial system
to cope with the increasing demands.

Hypertrophy

and hyperplasia cannot go on indefi171 t6ly.

Phago-

cytosis cannot keep pace with the coLtinued supply
of newly liberated toxic protein.
of this protein occurs.

Supersaturation

Eklund and Reimann (31)
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subscribe to this theory in the main, and stress
tbe effect of constant supersa.turation and hyperglobulinemia.

However, simple precipitation will

not explain the failure of genera.lized deposition
of amyloid in 211 the crevices of the tissue and the
occurrence of this deposit about the reticulo-endothelial cells.

A more prooable e:iq)le.nation may be

that the exhaustion, death and aisintegration of
the phagocytosed cells liberate ferments, enzymes
or other chemical substances which ere necessary for
the precipitation and deposition of the extracellular
amyloid.

Susman (:29) postulates that the spleen

alone produces such an enzyme; this enzyme interacts
with a soluble product of cell destruction which has
been conveyed by the blood--the result is arnyloid.
Hass and Schultz (V) in their recent paper point out
that it is not at all impossible that their protein
fractions "A 11 and "B 11 represent en antigen-antibody
type of complex.

If this tr;eory p1•ove to be true

then the antigen factor obviously will uc variable,
dependent as it must be upon the tissue breakdown
from chronic wasting or suppurative diseases.
SimilarJ.y the tissue antibody factor, if higr.:.ly
sµecific, likewise will not be of constant ch0mical

H1.

composition.

However, it is probably more than a

coincidence thE•t the extracellular amyloid is observed
just about the time that the phagocytic cells begin
to disintegrate.
Since the basic nature of this disorder is metabolic, ½.ualitative differences in diet may exercise
an influence on the formation of amyloid.

In all

the literature, I could find only one investigRtor,
Grayzel, et al (19), who attached any significance
to the diet as associated with experimental amyloid
production.

No figures are available as to the

clinical eff6ct diet alone may have on the disease,
nor are there clinical figures es to the value or
importance of high vitamin therapy.

Experimentally,

however, Grayzel reports that on the ordinsry stock
diet definite amyloioosis was produced in all of
a group of albino mice after from thirty to thirtyfive injections of casienate.

The condition beceme

progressively more marked with the increasing number
of injections.

On a highly adequate diet, hoirever,

the mice failed to show any evidences of amyloid.
until they had received at least sixty-three
injections.

Furtherr.c.ore, it was only after eighty-

one injections that they showed definite signs.

20.

These same investigators also studied the effect of
vitamins and found that mice fed a synthetic and the
so-called stock diet to which vitamins A and B were
added showed definite evidence of retardation of
the production and formetion of amyloid.

An ex-

planation may be th8t vitamins A and B play an important role in certain general metabolic processes,
and in the satisfactory function and growth of
organs (spleen end liver) and tissues (hematopoietic
and mesenchymal).

Since amyloidosis is a metabolic

disease in which the reticulo-endothelial cells
participate, an animal will dt-al more successfully
with a disorder when it receives ade~uate a.mounts
of food factors which are necessary for satisfact'Jry
metabolism and function of tlss,,es concerned wl th
the disturbance.

It is interesting to speculate on

the clinical aspects of diet and vitamins in this
disease.

If t~e incidence of this disease ls on

the dec1°ease, as is mentioned by Kole t sky end
Stecher (10) as well as others, one wonders what
effect the vitamin and diet conscious physician
has had on the decrease of the cases of sec~ndary
runyloiuosis, or whether the credit should go
entirely to the surgeon with his moderns rgical
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methods and drugs for the more effective prevention
of chronic sup~uration.

GENEhAL P 1":S.'HOLOGY Ur' SECONDJIJXY AMY"LOIDOSIS

Since the pathological and necropsy findings
are so numerous and so widespread with r-egrrds to
secondary amyloidosis, only e. few words need be said
about them, though the importance of these findings
must be slighted in the attempt to be brief.

Uni-

versally, the, findings of the different investigators
are similar.

Amyloid has been described in nearly

every orgen a.nd structure in the human bociy, thoc1gh
as has been stated previously, secondary amyloid is
usually found in the parenchymatous organs.

The

literature is filled with case reports in which the
autopsy findings are reported in great detail, and
experimental stu.d.ies are numerous on the localization
and pathological findings in amyloidosis.

Exba11stive

cese histories have been published by 9,olomon ( L(,),
Labbe, et al (3;,:;), Altnow, et al (.33), and numerous
others.

Dick and Leiter (34), Noble and Major (35),

and Grayzel (1~) have all done outstanding work in
experimental amyloidosis.

~~.

The amyloidosis of

humens and that of experimental animals is strikingly
similar in its localization, development and nature.
Th€ degree of anatomical damage in verious organs
is fully dependent on the severity of the amyloid
infiltration, but, in most cases, the localization
of amyloid is characteristic.
In the ordinary secondary form, which is by far
the most common, the amyloid appears beneath the
lining endothelium of ca.pillery vessels and around
the smaller arterioles in the intercellular spaces.
This especially is true around the central arterioles
of the splenic follicles where it produces the socalled "sago" spl~en.

Dick and Leiter (34) report

that the infiltration usually begins in the periphery
of the follicle and extends in~ard.

In the liver

the amyloid is found between the sinusoidal endothelium
and the liver cord cells centrally in the liver
lobule.

In thB kidney, and :11ore will be said of this

leter, tbe amyloid is found in the glomePular tufts,
again between the capillary endothelium and the
reflected epitLelium of the tuft.

Simil2.rly, it

m&y be deposited in the adrene.l glanus between the
sinusoidal endothelium end the cells of the fasicular
and glomerular layers of the cortex.

~3.

Elsewhere it

is found. particularly where reticule-endothelial
structures predominate, so that lymph nocies are
frequently the site of marked amyloid disease.

The

real importance of amyloidosis lies in the fact that
the amyloid may be formed in such large amounts as
to replace the normal cellular structures of an
organ and thus lead to impairment of its f,_mction.
Curiously, the selective distribution of amyloid
may vary considerably.

Experimentally Hass and

Schultz ( 9) have 1•eported that there is not only a
species suscaptibility to amyloidosis in the proposed ratio of rabbit, horse, man and mouse, but th0t
there is also an organ susceptibility in the order
of spleen, kidney, liver, end edrenal glend involvement.

Al though this or·gan ratio may vary consider-

ably clinically, it is for tbe most part true,
though as a rule, whenever found. in the spletcn it
is likewise present in the renal glomeruli a.r,d
of"ten in lerger amounts than is anticipated.

Often

times the process is limited to tbe kidneys and
even cases of Addison's disease, the result of
adrenal glrnd destruction, have been reported by
Hunter and Hush (36), Philpott (37), end Marani (38).
Secondary am.yloidosis of tbe beart bas been
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reported by Larsen ( 39) and von H"u.ebschmann ( 40) in
whose cases the myocardium was found to contain
emyloid deposits within connective tissue and vessel
walls, rarely in the endocardium and valves, and in
no instance was amyloid found in tbe muscles.

This

is in contradistinction to the case reported by
Budd ( 41) in ,vhich tbe substance was found a.bout
the muscle fibers in a cese of primary amyloidosis.
In the bone marro~, as reported by Gerber {4~),
runyloid is usually found in three forms, namely:
Isolated infiltrations of the vessels of the marrow
in generalized amyloidosls, massiVP accumulations

in the form of tumors, end lastly, o.eposited within
pre-existing blestomas or otterwise disease bones.
Gerber also states that there may be massive
accumulations in the skeletal pert of the ·bone.

OTr.bB FOhlviS OF A1tYL:.:.1L LIS.EASE

Primery amyloidosis end tumor forming e.myloidosis, though recognizea as entities, are extremely
rare.

There is no reference in the literature to

the possible etiology of' either.

Those wto h2.ve

reported cases have stressed (a) the absence of
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known etiological factors as are accepted for the
secondary form, end (b) the tendency to lnvolve tissues
of mesenchymal origin (smooth and skeletal muscle
especially).

Kiletsky end Stecher (10) in 1909

co;ld collect only twenty-six cases from the
li terat1.1re; I could find only f01~r others reported
since, the last two of which were reported by
rearson, et al (43) in 1941.
found tv.o cases in
Ne~roes.

B

'I.bis latt.er author

t_·,tal of 7,ol5 a.utopsies--both

All of the ot~er twenty-eight cases were

in the ~hite race.
In reviewing exta,:sti vely ee ell of t'Jl:er:ty-two
well reported and e.uthenic cases, Koletsky and
Stecher (10) are etle to divide primary amyloidosis
into localized and systemic tr~es.

One organ alone

may be involved, or systemic mesodermal struc~ires
may be involved.

In the twenty-two cases reviewed

by these tvo e_u ttor s tbe patients ages ren from
36 to 7~ years--the average was 52 years; the sexes
were evenly divided at eleven eech and all were
white.

'I'he cl ~-nicsl manifestations of primary

systemic amyloidosis was fairly uniform.

One of

the most constant f:indings is enlargement of the
tongue due to amyloid infiltration, with or without
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pain, and with dysphonia and. dysphagia in varying
degrees.

Such cases were reported by Beavis (44),

Mallow and Lebell ('±5), and Gertsel (48).

There is

occasionally an involvement of the facial muscles
and skin which may produce a fixed staring expression
resembling that of paralysis agitans.

Commonly there

is progressive weakness and fatigue due to involved
skeletal :muscles, as wes re_ported by Niichelson and
Lynch ( 46) , and. Warren ( ':1:7) •

In these cases dis-

turbanct sin gait and limitation of motion ~ere
fre':l.uent and d11e to involvement cf muscles, tendons,
and joints.

Infiltration of the intestine caused

constipation, diarrhea, abdominal pain, vomiting,
and meteorism in the cases reported by Mallow and
Le bell ( ,,u;), and Gertsel ( 48) •

'I'he skin is often

involved and is occasionally the only organ to ce
infiltrated.

To this phase of the dis~ase

Freudentt.al {4~) bave the name "Lichen Amyloio.osis"
when he first reported sucb a case in 1~3~.

Since

that time ceses heve been reported by Gray (50)
and Winer (51), end in these patients the only signs
of the disease were irritt,tive, hard, accuminate
papules.
Amyloid involvement of the heart occasionally
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leads to cerdiac insufficiency and such cases e.re
reported by L2rsen (39), Budd (41), Hasnisch (52',
anci Lindblom and Silwer ( 53).

It is diffic:,l t,

however, to correctly evaluate the cause and effect
relationship in these cases.

Purpura is a fre~uent

symptom and is presumably due to a~yloid infiltration
of the blood vessels.

The hemorrhage is most common

in the skin, but also occurs in the tongue and
mucous membranes.
bruise easily.

There may be a tendency to

Larrngeel obslruction is not at all

uncommon and is ,.,.resent in the cases reported by
Pearson (43), beavis (~4), and Haenisch (5G).
In summarizing twEinty-four cades which came
to autopsy, the following anatomical distribution
of primary amyloid was found (l<oletsky and Steeber, 10):
17 sho~ed involvement of the organs
of cardio-respiratory, gastrointestional, and skeletal systems
20 cases showed tongue involvement

19 cases sho~ed heart involvement
lo cases show8d gastro-intestionel
involvement
8 cases showed skin involvement

10 cases showed skeletal muscle involvement.
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Amyloidosis associated witb Multiple M.yeloma:
That muitiple myeloma is occasionally accompanied
by amyloid disease is well estabiished.

This

association is obviously too fre~uent to be merely
coincia.ental.
The first acc,_.unt of amyloidosis associated
with this condition wes published by Askanezy (54)
in 1904.

Amyloidosis of this type, though the same

substance as seen in other conditions, should not
be cle.ssified wi tb cases of emyloid tumor of the
bone.
8

Rath0r it should be considered separstely

s a special entity as a second.ary factor to the

blastometous multiple myelorna.
Many of the authors have considered this type
of amyloidosis as one of the types of prime.ry amyloid
and the possibility of myeloma must be considered
in every case of primary amyloid--tholgh none was
ever found in the cases reported on previously.

The

amyloid in these cases hes essentially the distribution
of idiopathic emyloid.

In the case reported by

Askanazy ( 54) the amyloid was fo,md principa.lly
infiltreting the musculature of 'the sme.11 :i.ntest:i.ne
whereas the rest of the abdominal viscere were
spared.

HandRll' s ( 55) case was strikingly similar.
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Paige ( 56) reported e. case of generalized amyloidosis
associated with widespread myeloma of the plssme_
cell type, but in wb.icl'.~ case there were l0rge intramuscular masses of amyloid.

Bueter ( 27) reported

an early case in 1910 in which the amyloid was
foc1nd in the usual sites of the spleen, liver, and
kidney.

He ~ekes no mention of any other form of

disease or infection in his report of the case.
From the few cases thus reported, it can be safely
concluded that there is no regularity of amyloid
deposition when associeted with multiple myeloma.
Another ergurn.ent tbet is frequently aiscu.ssed
in the li ter·a ture is the relationship between
amyloid and the Bence-Jones protein found in cases
of multiple myeloma.

Tbout,h this is still an open

debate, popular opinion is thnt the two are closely
relF;ted. chemicslly

(Koletsky and Stecher, 10).

Gerber ( '±i) suggests tLet the Bence-Jones pr·otein
of myeloma is the matrix of tte amyloid.

Magnus-

Lev:y- suggests thet the primary ruuyloid tumors of
the bone are instances of multiple myeloma with
secondsry emyloid deposits rattier than idiopathic
amyloid tumors, the amyloid h~ving arisen from the
Bence-Jones protein.
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RENAL AMYLOIDOSIS

Amyloid disease of the kidneys bas attracted
considerable attention in the literature for two
reasons:

first, because renel failure 1s the terminal

event in a few of the cases of generalized amyloidosis,
and is more common than was once believed, and
second, because kidney function in cases of generalized
amyloidosis is so readily studied clinically.
Renal insufficiency and con~racted kidneys
in amyloid disease were first describeci by Wagner (b7)
in ldol.

For many years it was believed that renal

amyloia.osis was not associated with renal insufficiency
and thst uremia was a. rarity.

'I'he term amyloid

nephrosis has served to convey the impression thet
the course of amyloid disease of the kidney was
similar to that of amyloid nephrosis, and therefore
azotemia was not to be ex~ected.

In recent years,

however, renal runyloidosis terminating in uremia
has been reported with incr~asing frequency.

Dixon

{20) noted azotemia in 12 cases of 100, Bell (58)

in 11 of 65 cases end Rosenblatt (15) ln 8 of 8'7

cases.

Noble and Major (06) reported three cases

with term nal uremia.
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There seem to be three generally accepted
conceptions of this pathologic~l entity.

The first

was advanced by Fahr (5~) who divided the morphologic
changes of the amyloid kidney into four sta.ges:
Stage 1:
only a minimal amount of
amyloid in the glomeruli, together with a moderate degree
of albuminour degcneretion of
the tubules.
Stage 2:
larger amounts of amyloid
in glomeruli and mo~e marked
tubular degeneratio~ with
hyaline granules.
Stage 3: Large amounts of amyloid
with consequent narrowing of the
capillaries with the glomeruli
still permeable to blood flow.
Stage 4:
glomeruli destroyed with
marked tubular atrophy secondarily.
Fahr believed thst the disee.se is

R

toxic process

effecting both tubules and glomeruli simul taneousl;y;
the primar-y damage being done to tbe glomer11li.

'I'he

second conception is thet expressed by Osler and
Mccrae (60) in v,hicb amyloid infiltration occ,.irs in
the course of chronic nephritis.

Maccallum (61) was

another wbo believed th!:!t amyloid is deposited in
any of all of the changes described in progressive
nepru:~itis.

Maccallum elso stated, however, that

amyloid may appeer in an otherwLrn normal kidney in
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tL.e

course of generelized amyloidosis.

'I'his idea

repr'e8ents the tbird conception, namely that it is
simply a pBrt of a systemic condition in which the
da..'11> ge to the kidney may be the most prominent
feature.

It is this third conception which is

most subscribed to by modern investigators, and
which is in keeping with the accepted fact that
amyloidosis is most commonly a se-1.uele to chronic
suppuration.

The etiology of amyloid disease as it

effects the kidneys is the same es that which is
found in any other organ.

It cher.i.ical nature is

also similar to that of other erees.
Dixon (~O) states that the histopathologic
picture of renal amyloidosis in its late stages is
similar in some respects to that of the small
granular kidney of chronic glomerulonephri tis and
in tLe later stages or arteriolar nephrosclerosls,
mainly in the elteration of the arch3..tecture by the
irregular overgrowt:r~ of the fibro\1s tissue in the
stroma, lymptocytic infiltration in the patches of
fibrosis, end dilitstlon or atrophy of the tubules.
In the stage of exayloici disease rt)sul ting in
rcns_l insufficiency_, amyloid is present in such
massive amounts that the capillary bed of many
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glomeruli is occl,Jded ( Dixon, 20) •

The glomeruli

containing emyloid are somewhat larger than normal
and as a rule there is a slight tlickening of the
ce.pS1Jle of Bowman with no proliferation of the cells
of the glomerular tuft.

The walls of the arterioles

are definitely thickened and their lumina are
nar1:owed., but in no case is complete obli teretion
of th6 lumen the general rule.

'l'he runyloid deposits

are characTeristically found in th~ media of the
arterioles and the thickening of the walls of the
vesseis as a resitlt of amyloid deposits in this coat
resul 1:s in the narr·owing of tbe lumc~n.

In chronic

glomerulonephritis 1:;he char·r,cteristic pict1u:•e is the
change in the glomeruli which are sbr-..;;nkcn and. often
appeai" as balls of fibro-., s tissue showing complete
or partial hyelinization end marked thickening or
Bo~man 1 s caps~le.

In arteriolar nephrosclerosis,

the arteriolar changes are from tbjckened walls es
a result of intim&l sclerosis, while in amyloidosis
the thickenint is principelly the res1.,l t of deposition
of e111yloid in the media of the vessels.

In addition,

the glomeruli sbow lobulBtion of the tufts with
slight thickening of tbe walls of the individual
capill~ries, end often pr~sent changes similsr
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1:0

those seen in cbronic glomerulonephritis which
result second~rily from loss of blood supply to
them, a.ue to occlusion of tbe efferent arterioles.
Troisier (b~) and his coworkers sho~ed that
rene.l anryloia.osis may manifest itself ln several
v.ays ana. that other degeners.tive and inflarmnatory
disee.ses of the kidney may be simulated by amyloidosis in one or more of its stages.

The symptomatology

in these cases is ir, the main that of tbe major
illness end there is no special symptomatology of
tLe renal aruyloidosis per se, as it is frequently
fo~nd

bDd

associsted with lipoid nepbrosis and is

often found in the kidneys which stow the lesion
of glomerulonephri tis.

True lipoid nephr·osi s and

a.:myloidosis may exist independently of eacb other.
The main factor in the development of renal
symptoms would appeer to be the amount 1,nd extent
of &1uyloid deposited in the kidneys.

-With little

a.:myloid in the glomerulus tt,.ere may or may not be
enol,gh injury to tr~e glomer11lar cepillflries to
allow slbumin to escPpe into the urint!.

With l&rger

deposits of a..myloid, there is more extensive injury
to the glomerular capillaries and a larger amount
of albumin escapes.

In soms instances the loss of
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this protein is great enough to result in a lowering
of the osmotic pressure of the r,lasma, so the.t edema.
occurs.

In thE cases studied by Bell (bd) it was the

a.ppeerimce of albuminurie or edema. that first
directed attention to tbe kidneys--and this wes
usu.elly ,iust

8.

few months prior to the terminf1tion.

When tht amyloid deposits are extensive, destruction
of varying amounts of the renal parench-ynie follows
and renal insufficiency may ensue.
The destruction of the ren2l tissue and its
replacement by fibrous tissue is apparontly the
res lt of obstruction of the efferert arteriole or
occlusion of the ca.pillaries of tbe glomerulsr tuft
by deposits of Hmyloid.

As stated earlier, the

chief site of' the runyloid as reported by Dick and
Lieter (34), is between the capillary endothelium
and the reflected epithelium of the tuft.

'I'he

tubules lea.ding from the destroyed glomerl,11 undergo atrophy and arE:c ref•laced by fibrous tistme v.hich
results in e scarred and more or less contracted
kidney similer in many respects to an adve.nced
arteriolar nephrosclerosis or the late ste_ge of
cl1ronic glomerulonephri tis.
Observations mede from 11rina.nalysis by Bell ( 58),
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Hiller, et al (60), and Altnow, et al (33) show
thst albuminuria is present in all cases in which
there is more than a slight alllount of renal amyloid.
In the later stages, however, Mvrk end Mosenthal (ci4)
could find no direct correlation between the degree
of renal amyloid infil tr·&tion 1cnd the degree of
albumiff1.cie..

Urinary proteins in amyloidosis are

very low f'or tbe aTbumin frBction.

Hiller and bis

coworkers (63) found the albumin-globulin ratio of
urin1:1.1.·y 1Jroteins usually above ten in nephrosis,
between five and ten in s.cu te nephri t:i s and. slightly
be-low five in chronic glomerulonepbritis.

In com-

perison tc these fig·,,res were those found in amyloid
nephrosis in which the A-G ratio was very low et
one end one-he.lf.

This figure is from only one case.

bell (58) stat8s that globulin sometimes exceeds
e.lb1.1min in content.

Other findings may be an

occasional slight hemalurie, end cylindruria is not
uncommon.

rell believes tLat the casts correspond

to the degree of renal amyloidosi s.

However·, the

cnsts found in the urine do not give the amyloid
staining reActions with the verious steining
techni~ues, but nevertheless, they often obstruct
the t1.jbular lumen, ca·d.sing dili tation &nd sometimes
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atrophy.

Saleeby (lb) found casts in forty-five

of fifty patients and only one of these gave a
do· ;btful amyloid stain, sbowing that speclficslly
staining amyloid probably plays no part in the
forming of amyloid casts.
Most investigators find hypertension conspicuous
by its absence in these cases of renal involvement.
Mark and :,1osent.t,al ( o4) state that this cannot be
ettrib1,ted to cachexia because the genersl condition
of these ;rntients remains fairly good U'itil shortly
oefore death.

Alt~ow, et al (33) states that the

en,yloici kidne:r is charecterized by tbe absence of
hypertension &nd car'diac hypertrophy.

In tr1e one

t..undrsd cases st died by Dixon ( 20) only l~~: r1ac, a
systolic pressure above 150 mm. ana

·c:, .es6

f" tients

were in the older age groups.

DIAGiOSTIC VALLE OP THE CONGO RED fLST

The value of the Congo red test in the diagnosis
of a.mylo1dos1s hes been sePiously y_uestioned by the
recent workers in this field.

Congo red was first

recommended for the diagnosis of renal distases by
Bennhold (75) in l'i:,;::;?;.

He wrote that "in normal

38.

individuals, about eleven to thirty per cent of
intravenously injected Congo red diseppeers from
the blood within the first hour, while in patients
with extensive amyloidosis, 40% to 100% disappears
during the same pericdn.

Tbe fundamental principle,

though emphasized by Bennhold, namely the electivity
of Congo red for amyloid substance, was not sufficiently
appr1:;ciated in its tr,-1e significance, specifically
fo~ the possible determination of amyloid infiltration
during life.

Vivoli (7b) is entitled to some credit

for having restricted the Bennhold reection to tbe
only pathol0gical condition for the clinical diagnosis
of which it is ac~1elly serviceable.
Labbe and his coworkers (77) are of the opinion
that this test is of~ definite value in making a
diagnosis, but its interpretation is certBinly more
complex than was believed by the German a\::.tbors who
proposed it.

There are three principal factors

which may cause error in the interpretation of this
test.

These Bre tbe diffic-,Jlties of determ ning

the dye in the ser·v_m, the presence of e_ syndrome of
lipoid nephrosis and the influence of the reticuloendothelie.l system end the state of the liver.
The approved present de_y technique of this test
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is the injection intrevenously of a one per cent
solution of Congo red in distilled water.

The

dosage is O.Oo cc. per kilogram of body weight.
Blood is tLcn collected one-hslf hour, one hour and
one end a h&lf ho-..1rs l8ter from a vein in tbe oppoo i te
arm.

'l'L"'se small samples of blood are left in tubes

until there ls spontaneous coagulation or it may
oe centrifuged imrnedia tely in tu-bes containing
potassium oxalate.

The color of tbe se1~um or plasma

is then compm·ed with that of nor·mal serum or plasma
and with colcr comparison charts or t1,;bes.
Ttough recent investigators attech less
significance to the Congo red test, it is still con:::.i6.ei'ed diagnostic under given conditions.

'11he

positive confirmatory test is now more or less limited
to a higher percentage absorption than wes suggested
by the earlier workers.

Lipstein's (78) evaluation

of this test is interesting.

In a series of 125

tuberculosis patients he correlated the percentage
of dye absorbed with the presence or absence of amyloia
at autopsy and concluded the te0ts could be interpreted
I

as confirmatory evidence of amyloid disease only
when the percentage of dye absorbed was 90'.\S or r_;igher.
The work of ~allace (80) and Hardgrove (79)
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~Jpports

the conclusions of' Lipstein.

Thus we must alter the

opinions of the eerlier workers so that only wLen
higher percentages of the dye is absorbed is t,bere
any indication to suspect amyloidosis--and this
must be coupled

¥ 1i

th the rRther definite clinical

findings of cacbexia, enlerged livc:r, end enlarged
spleen.

Furthermore, the considerations mentioned

by Labbe (77) must also be kept in mind in making
a final interpretation of tbe t6st for diagnostic
purposes.

TREATMEN1

It he.s long been thought thet once emyloid had
infiltr8ted an organ it could not be reabsorbed.
Ho~ever, recent experimental and clinical evidence
seems to have discredited this view.

Kuczynski

<~~)

was e..cle to produce emyloid experimentally in mice
by the injection of casein and, by biopsy from the

liver he we..s eble to demor!.strPte tbet e.myloid would
disappear if the injections of protein were discontinued.
One can find very few cases in the literature
in which recovery has been reported once amyloid
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has begun to b€ deposited.

Waldenstrom (b5) stated

in 1928 th8t he could find no record in the literature
of an established cese of emyloidosis in which the
process hed unaergone retrogression or in whicb
the patient had recovered.

In 1940, Pearlman ( 06),

who hes contributed m ,ch to the literature on this
0

subj6ct, refers to recovery from amyloidosis as an
"extreme rarity".
However, as time goes on and more and more
material accumulates from various sources it is
evident thet recoveries are more common than most
workers had been inclined to believe, that recovery
from advanced amyloidosis must still be considered
rere, while in the milder cases it is not uncommon.
Differentiation should, therefore, be 1m,de between
mild and advanced fulminating forms of the disease
and also those wt.ich tend to become more ch1~onic.
The c~arrcter and severity of the disease v~ry witb
the patients ability to take care of excessive
tissue protein destruction a~d the severity of the
insult from the in.fected focus as well as the speed
and effectiveness with which this focus can be
elimineted.

Grayzel.(Hi) states, tton the other

hand the longer the amyloid resides in the tissue,
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the more difficult does it become to disintegrate
and eliminate this material.

This may account for

the apparent retardation during the second stage in
the resorption or amyloid 11 •
Walker (b7) reported the first case of rec~very
in a...'nyloidosis.

His patient was a four yeBr old

boy with post-pneUY.:onic emi-yems wbich vvas repeatedly
drained but which remained open for t·,rn and one
half years.

The child became cachetic, the liver

and Sflcen greatly enlarged and amyloid was demonstrated.
Following treetment by thoracoplasty there was free
areining and healing of the local infection followed
by diminution in the size of the liver and spleen.
After eight years ttJere was no evi<ience of anryloidosi s.

The case reported by Beardsley (68) is

markedly similer to that of Walker and represents
the disease in its most severe form, and again tends
to indicate that recovery is due to complete elimination
of the focal source of infection.

This has been

the experience of others such as Habein ( b9),
Waldenstrom

(06), Reimann (70), and Rosenblatt (71).

The surgery performed in these latcer cases, however,
wf!s of a minor nature.
~bitbeck (72) reported in 1932 the results of
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medical treatment of amyloidosis in seven children
with Pott 1 s disease.

The diagnosis was made by the

usual clinical findings as well as by positive Congo
red tests.

His treatment, in addition to general

measures, consisted in the administration of four
grams of concentrated, powdered, v.hole liver daily.
Of the seven children so tre&ted, all showed clinical
improvement, al tbough two C:i.ied of interc1~1rren t
pulmonary infections.

The remaining five gave no

clinical evidence of amyloidosis at the end of twelve
and eighteen months.

Their generel condition had

improved, secondary anemia h&d disappeared, and they
were apparentLy well on the roed to complete recovery.
Grayzel (19) reported that experimentally
poVvdered whole liver added to the diet of experimental
animGls not only speeded resorption of the amyloid
b1.,, t also retarded formation and production of tbe
a..,nyloid materiA.l.

He

speculates that this may be

due to the pretF,nce of an 2.ctive potent principle in
the liver which is necesssry for the C')ntinuance of
the reversible process, or tlrnt it may further
stimule.te the reticulo-endothelia.l system to the
result of overcoming the pa.tbological protein substances which 1:_,o to make up amyloid.
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Gayzel and Jacobi (73 and 74) followed up the
work of Whitbeck and their own experimental work by
administering clinica.lly liver extract to 13 patients.
'11.l:leir method was to prepare a Hli ver cocktail" from

fresh liver by straining the liver through a fine
sieve toe pasty consiste-ncy, then A.dding any one
of sev8ral fruit juices suitable to the patient.
The dosage varied from the e~uivalent of one-fourth
to three-fourths of a pound of liver daily.
res1.ll ts are mildly gratifying.

Their

The accompanying

chart summsrizes the results of the work of Gre.yzel
and Jacobi.

'Ii,e basis of improvement or cure in

these cases is evidence in reduction in si~e of the
abdomen, liver and spleen, with reduced tortuousity
of the superior epigastric veins follo~ed by
improved general 0.)pearance and condition of the
patient.

Grayzel states that with the exception

of two phenomena, i.e. albumim1ria end positive
Congo red test, &11 o-cher signs end. sym.ptoms of
amyloidosis has a.isa_ppeered within two to three
y6ars ~fter onset of liver therapy, and that even
in those cases that died tr.ere was improvement in
the amyloid conditjon.

However, it must be admitted

that -che medical treatment is a slow and laborsome
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process, with a questionable valu e, and as yet too
fe w cas e s are reported to attach a definite
si gnificance to this treatment.
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SUMMARY

After a rather comp lete review of the literature,
the following concl u sions may be drawn in summary
as to the present status of the amyloidosis problem.
1.

Amyloidosis is a rare condition and is less

common nowadays than a half century ago.
2.

Amyloid probably does not co n tain chondroitin-

sulfuric acid, b u t nevertheless it is a complex
protein substance, varied in its composition and
con sists of a number of different amino acids.

It

is u n affected by pe~tic digestion, insoluble in
water, slightly soluble in strong acids, and readily
solu ble in strong alkal is.
3.

In classifying amyloidosis there are four types:

(a) secondary, (b) primary, (c) amyloidosis associated
with multiple myeloma, and (d) tumor forming
amyloidosis.
4.

Secondary amyloid is a complication of chronic

suppurative diseases.

It is an infiltrative rather

than a degenerative process in which there is an
abnormal hyperglobulinemia from excessive tissue
des~ruction and an altered endogenous protein
metabolism.

Areas of infiltr c tion show predilection
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for involvement of the reticulo-endothelial system
which is unab l e to cope wi th the increasing demands
of the altered endogenous protein metabolism.

Per-

haps there is an enzyme that is necessary for the
precipitation and deposition of the extracellular
amyloid.
reaction.

Or, perhaps it is an antigen-antibody
Highly adequate diet probably effects

adversely the formation and favorably the retrogression of amyloid.
5.

Secondary amyloid is usually found in the

parenchymatous organs, usually extracellularly, and
is most common in the spleen, kidneys, liver, adrenals,
and lymphogenous tissu es.

The real importan ce of

amyloidosis lies in the fact that it may be formed
in such large amounts as to replace the normal
cellular stru ctures of an organ and thus lead to
impairment of its function.
6.

Primary amyloidosis is a rare con dition char-

acterized by (a) the absence of known etiological
factors as are accepted for the secondary form, and
(b) the tendency to involve the tissues of mesenchymal
origin (smooth and skeletal mu scles especially).
7.

Multiple myeloma is fre~uently associated with

amyloid dise ase whi ch has the distribution o
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idiopathic amyloid. · The Bence-Jones protein and
amyloid are closely related chemically.
8.

The kidneys are favorite organs of clinical

study when involved in amyloidosis, and renal failure
is not uncommon.

Kidney involvement varies in

degree and is a part of a systemic condition.
Renal function is altered in direct relation to the
degree of glomerular destruction and tubular atrophy.
The late stage of renal amyloidosis is similar to
the small granular kidney of chronic glomerulonephritis
and arteriolar nephrosclerosis.

Albuminuria and

edema are common with this condition whereas
cylindruria and hypertension are not present.
9.

The Congo red test is of diagnostic value only

when 90% or more of the dye is removed from the
peripheral blood in one hour.
10.

Treatment of primary amyloidosis is unknown

other than surgical removal of the localized
e.c.c umulations.

Early surgical and medical treat-

ment of the foci of chronic suppuration is probably
the best, though indirect, treatment of secondary
amyloidosis.

Medical treatment of the amyloidosis

per se by the administr 8tion of whole liver is only
mildly gratifying .

Too few cases have been reported
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for the efficacy of such tre a t ment to be established.
Such treatment alone is probably of little value
u nless accompanied by generalized care and
elimination of the primary suppurative process.
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